Kuvura Ibiyobyabwenge Gutanga Ibiyobyabwenge kuri kanseri

Iyi ngingo itanga incamake yuzuye ya Kuvura Ibiyobyabwenge Gutanga Ibiyobyabwenge kuri kanseri, kora uburyo bwacyo, inyungu, ibibazo, hamwe nubuyobozi buzaza. Twashuka inzira zitandukanye, harimo nanotechnology, antibody-ibiyobyabwenge-ibiyobyabwenge, no kuvura gene, gusuzuma ibyifuzo byabo no ubushakashatsi bukomeje. Wige ibyiza byubuvuzi bwintego ugereranije na chimiote gakondo nimbaraga zikomeje kugirango utezimbere kandi ugabanye ingaruka.

Uburyo bwo gutanga ibiyobyabwenge

Nanotechnology-Bishingiye kubiyobyabwenge

Nanotechnology igira uruhare rukomeye muri Kuvura Ibiyobyabwenge Gutanga Ibiyobyabwenge kuri kanseri. Nanoparticles, kubera ubunini bwabo nubushobozi bwabo bwo kwinjira mu ngingo, irashobora gutanga abakozi ba chemitherapeutic kugeza kuri selile, kugabanya ibintu bifatika. Ubwoko butandukanye bwa nanoparticles, harimo liposomes, na polymeric nanoparticles, na anorganic nanoparticles zabo, irasakuza kubushobozi bwabo mugutezimbere ibiyobyabwenge no kugabanya uburozi. Kurugero, Liposoal Doxorubicin (Doxil) ni ubuvuzi bwemewe bwo gutanga ibiyobyabwenge bigabanya imitisi ugereranije na doxorubicicic isanzwe. Ubushakashatsi bukomeje guhitamo Nanoparticle igishushanyo mbonera cyigituba cyateye imbere na kinetike y'ibiyobyabwenge. Ikigo cy'ubushakashatsi cya Shandong

Antibody-ibiyobyabwenge (ADCs)

ADCS igereranya indi ngamba zingenzi muri Kuvura Ibiyobyabwenge Gutanga Ibiyobyabwenge kuri kanseri. Aba bakozi ba therapeutic bagizwe nibiyobyabwenge bya sitotoxique bifitanye isano na antibody monoclonal yibasira selile kanseri. Ubu buryo buremeza ko ibiyobyabwenge bitangwa byatoranijwe mu kagari ka kanseri, kugabanya ingaruka zigamije no kuzamura urutonde rwa Trapepeutic. Ingero za ADC zemewe zirimo Trastuzumab Emtine Emtine (Kadcyla) kuri kanseri ya hel-nziza nziza na bdoximab vedotin vedotin (adcetris) kuri hodghoma. Gukomeza Ubushakashatsi bwibanda ku kuzamura antibody bibasira umwihariko no guteza imbere uburenganzira bwa cytotoxique.

Gene THERAPY yegera

Ubuvuzi bwa Gene itanga inzira yo gutangaza Kuvura Ibiyobyabwenge Gutanga Ibiyobyabwenge kuri kanseri. Ubu buryo bukubiyemo ingirabuzimafatizo mu ncamake ya kanseri kugirango ibuze ibibyimba cyangwa kuzamura ubushobozi bw'umubiri w'ubudahangarwa bwo kurwanya kanseri. Viral Velics zisanzwe zikoreshwa mu gutanga ibigo bya TheRapeutic kugera kuri selile. Ubundi bushakashatsi bushakisha uburyo bwo guhindura Gene nka Crispr-cas9 kugirango bahindure neza generafiya kandi itezimbere.

Ibyiza nibibazo byatanga ibiyobyabwenge

Sisitemu yo gutanga ibiyobyabwenge itanga ibyiza byinshi kuri chimiotherapi isanzwe, harimo neza, yagabanije uburozi, kandi yongere imbaraga zo kwihanganira. Icyakora, ibibazo bisigaye, birimo iterambere ryo kurwanya ibiyobyabwenge, hakenewe kwibiza kwibasira, n'ikiguzi kinini cy'abacuruza.

Imbonerahamwe 1: Kugereranya uburyo bwo gutanga ibiyobyabwenge

Icyerekezo kizaza mu gutanga ibiyobyabwenge bya kanseri

Ubushakashatsi bukomeje bwibanda ku gukemura aho ubushobozi bwo gutanga ibiyobyabwenge bugenewe ibiyobyabwenge no guteza imbere igitabo. Ibi birimo uburyo bwo gutera ibiyobyabwenge umwihariko, kuzamura ibiyobyabwenge kuri kinetike, no gutsinda ibiyobyabwenge. Kwishyira hamwe kw'ingamba nyinshi zigamije, imiti yihariye yegereje, hamwe niterambere rya sisitemu yo gutanga ibiyobyabwenge ziteganijwe kuzamura imikorere n'umutekano wa Kuvura Ibiyobyabwenge Gutanga Ibiyobyabwenge kuri kanseri. Ubundi bushakashatsi ku bigo nka Shandong Baofa Kanseri Ikigo cyubushakashatsi ni ngombwa mugutezimbere uyu murima.

Kwamagana: Aya makuru ni agamije kwiga gusa kandi ntagomba gufatwa inama zubuvuzi. Buri gihe ujye ubaza umunyamwuga wubuzima kubibazo byose byubuzima cyangwa mbere yo gufata ibyemezo bijyanye n'ubuzima bwawe cyangwa kuvura.

INGINGO: .